| Nomenclature | CD80 | CD86 | cytotoxic T‐lymphocyte‐associated protein 4 (CD152) | programmed cell death 1 (CD279) | CD300a |
| HGNC, UniProt | CD80, P33681 | CD86, P42081 | CTLA4, P16410 | PDCD1, Q15116 | CD300A, Q9UGN4 |
| Common abreviation | – | – | CTLA‐4 | PD‐1 | – |
| Antibodies | – | – | ipilimumab (pK d>9) [28], tremelimumab (pK d 8.9) [30] | pembrolizumab (pK d∼10) [11], nivolumab (pK d 9.1) [28, 38, 40] | – |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.